Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthias Pfisterer

Showing results (21-30 of 87) with videos related to

Pageof 9
Sort By:
International Journal of Cardiology|August 22, 2017
Prasugrel vs. clopidogrel in contemporary Western European patients with acute coronary syndromes receiving drug-eluting stents: Comparative cost-effectiveness analysis from the BASKET-PROVE cohortsBastian Wein, Michael Coslovsky, Reza Jabbari, et al.
European Heart Journal|January 22, 2010
Influence of functional deficiency of complement mannose-binding lectin on outcome of patients with acute ST-elevation myocardial infarction undergoing primary percutaneous coronary interventionMarten Trendelenburg, Pierre Theroux, Amanda Stebbins, et al.
European Journal of Internal Medicine|September 29, 2009
Coronary artery disease is common in asymptomatic patients with signs of myocardial ischemiaAndreas W Schoenenberger, Peiman Jamshidi, Michel Zuber, et al.
British Journal of Clinical Pharmacology|September 19, 2007
Sublingual administration of furosemide: new application of an old drugLaurent Haegeli, Hans Peter Brunner-La Rocca, Markus Wenk, et al.
American Heart Journal|April 29, 2006
Management of elderly patients with congestive heart failure--design of the Trial of Intensified versus standard Medical therapy in Elderly patients with Congestive Heart Failure (TIME-CHF)Hans Peter Brunner-La Rocca, Peter Theo Buser, Ruth Schindler, et al.
Clinical Cardiology|June 1, 2010
Progression of coronary artery disease during long-term follow-up of the Swiss Interventional Study on Silent Ischemia Type II (SWISSI II)Andreas W Schoenenberger, Peiman Jamshidi, Richard Kobza, et al.
Postepy W Kardiologii Interwencyjnej = Advances in Interventional Cardiology|December 17, 2016
First-generation paclitaxel- vs. second-generation zotarolimus-eluting stents in small coronary arteries: the BASKET-SMALL Pilot StudyRaban Jeger, Matthias Pfisterer, Otmar Pfister, et al.
European Heart Journal|July 24, 2007
Effects of anti-ischaemic drug therapy in silent myocardial ischaemia type I: the Swiss Interventional Study on Silent Ischaemia type I (SWISSI I): a randomized, controlled pilot studyPaul Erne, Andreas W Schoenenberger, Michel Zuber, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 17, 2009
Early and late increased bleeding rates after angioplasty and stenting due to combined antiplatelet and anticoagulanttherapyChristophe Hälg, Hans Peter Brunner-La Rocca, Christoph Kaiser, et al.
Journal of the American College of Cardiology|December 4, 2003
Heart rate variability and cardiac troponin I are incremental and independent predictors of one-year all-cause mortality after major noncardiac surgery in patients at risk of coronary artery diseaseMiodrag Filipovic, Raban Jeger, Cecilia Probst, et al.
Pageof 9

Showing results (21-30 of 87) with videos related to

Sort By:
Pageof 9
International Journal of Cardiology|August 22, 2017
Prasugrel vs. clopidogrel in contemporary Western European patients with acute coronary syndromes receiving drug-eluting stents: Comparative cost-effectiveness analysis from the BASKET-PROVE cohortsBastian Wein, Michael Coslovsky, Reza Jabbari, et al.
European Heart Journal|January 22, 2010
Influence of functional deficiency of complement mannose-binding lectin on outcome of patients with acute ST-elevation myocardial infarction undergoing primary percutaneous coronary interventionMarten Trendelenburg, Pierre Theroux, Amanda Stebbins, et al.
European Journal of Internal Medicine|September 29, 2009
Coronary artery disease is common in asymptomatic patients with signs of myocardial ischemiaAndreas W Schoenenberger, Peiman Jamshidi, Michel Zuber, et al.
British Journal of Clinical Pharmacology|September 19, 2007
Sublingual administration of furosemide: new application of an old drugLaurent Haegeli, Hans Peter Brunner-La Rocca, Markus Wenk, et al.
American Heart Journal|April 29, 2006
Management of elderly patients with congestive heart failure--design of the Trial of Intensified versus standard Medical therapy in Elderly patients with Congestive Heart Failure (TIME-CHF)Hans Peter Brunner-La Rocca, Peter Theo Buser, Ruth Schindler, et al.
Clinical Cardiology|June 1, 2010
Progression of coronary artery disease during long-term follow-up of the Swiss Interventional Study on Silent Ischemia Type II (SWISSI II)Andreas W Schoenenberger, Peiman Jamshidi, Richard Kobza, et al.
Postepy W Kardiologii Interwencyjnej = Advances in Interventional Cardiology|December 17, 2016
First-generation paclitaxel- vs. second-generation zotarolimus-eluting stents in small coronary arteries: the BASKET-SMALL Pilot StudyRaban Jeger, Matthias Pfisterer, Otmar Pfister, et al.
European Heart Journal|July 24, 2007
Effects of anti-ischaemic drug therapy in silent myocardial ischaemia type I: the Swiss Interventional Study on Silent Ischaemia type I (SWISSI I): a randomized, controlled pilot studyPaul Erne, Andreas W Schoenenberger, Michel Zuber, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 17, 2009
Early and late increased bleeding rates after angioplasty and stenting due to combined antiplatelet and anticoagulanttherapyChristophe Hälg, Hans Peter Brunner-La Rocca, Christoph Kaiser, et al.
Journal of the American College of Cardiology|December 4, 2003
Heart rate variability and cardiac troponin I are incremental and independent predictors of one-year all-cause mortality after major noncardiac surgery in patients at risk of coronary artery diseaseMiodrag Filipovic, Raban Jeger, Cecilia Probst, et al.
Pageof 9